Literature DB >> 24824238

Epidemiology of acute kidney injury in intensive care septic patients based on the KDIGO guidelines.

Qianyi Peng1, Lina Zhang1, Yuhang Ai2, Lemeng Zhang1.   

Abstract

BACKGROUND: Acute kidney injury (AKI) is a common complication of sepsis, which is associated with higher risks of adverse outcomes. Recently, kidney disease: improving global outcomes (KDIGO) recommended a new guideline for AKI, including a little modification on the AKI staging criteria.
METHODS: This retrospective study included 211 septic patients admitted to the intensive care unit (ICU) at Xiangya Hospital, Central South University from January 2008 to January 2011. AKI was diagnosed and classified according to the KDIGO or acute kidney injury network (AKIN) criteria. Differences between the AKI and non-AKI groups for baseline characteristics, laboratory examinations, etiology, outcomes, as well as the risk factors for AKI and 28-day mortality were analyzed. The reliability of the KDIGO criteria was also evaluated by comparing it with the AKIN criteria.
RESULTS: The overall incidence of AKI in septic patients was 47.9%, and the 28-day mortality was 32.7%. The incidence of AKI was significantly higher in patients with more severe sepsis. Indicators of hepatic and respiratory function were significantly worse in the AKI group. Furthermore, a higher proportion of patients were infected with Enterobacter cloacae in the AKI group. The independent risk factors for AKI were shock, the number of organ failures, blood urea nitrogen (BUN) levels, and the use of vasopressors. The independent risk factors for mortality were BUN and creatine kinase-MB (CK-MB) levels. Both the KDIGO criteria and the AKIN criteria were significantly associated with 28-day mortality.
CONCLUSIONS: The incidence and 28-day mortality of AKI were very high in ICU septic patients. Greater attention should be paid to AKI-induced hepatic and respiratory dysfunction in clinical practice. Patients with an intra-abdominal source of infection were more likely to develop AKI. KDIGO criteria are reliable in AKI staging.

Entities:  

Mesh:

Year:  2014        PMID: 24824238

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  12 in total

1.  The effect of thymoquinone treatment on the combined renal and pulmonary toxicity of cisplatin and diesel exhaust particles.

Authors:  Badreldin H Ali; Mohammed Al Za'abi; Asem Shalaby; Priyadarsini Manoj; Mostafa I Waly; Javed Yasin; Mohamed Fahim; Abderrahim Nemmar
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-28

2.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  Acute Med Surg       Date:  2018-02-05

3.  The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  J Intensive Care       Date:  2018-08-13

Review 4.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

5.  A pulmonary source of infection in patients with sepsis-associated acute kidney injury leads to a worse outcome and poor recovery of kidney function.

Authors:  Yi-Wen Fan; Shao-Wei Jiang; Jia-Meng Chen; Hui-Qi Wang; Dan Liu; Shu-Ming Pan; Cheng-Jin Gao
Journal:  World J Emerg Med       Date:  2020

6.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  J Intensive Care       Date:  2018-02-02

7.  A systematic review and meta-analysis of acute kidney injury in the intensive care units of developed and developing countries.

Authors:  Fernando de Assis Ferreira Melo; Etienne Macedo; Ana Caroline Fonseca Bezerra; Walédya Araújo Lopes de Melo; Ravindra L Mehta; Emmanuel de Almeida Burdmann; Dirce Maria Trevisan Zanetta
Journal:  PLoS One       Date:  2020-01-17       Impact factor: 3.240

8.  Skeletal Muscle-Derived Stem/Progenitor Cells: A Potential Strategy for the Treatment of Acute Kidney Injury.

Authors:  Egle Pavyde; Romaldas Maciulaitis; Mykolas Mauricas; Gintaras Sudzius; Ernesta Ivanauskaite Didziokiene; Arvydas Laurinavicius; Neringa Sutkeviciene; Edgaras Stankevicius; Justinas Maciulaitis; Arvydas Usas
Journal:  Stem Cells Int       Date:  2016-03-16       Impact factor: 5.443

9.  Value of Kidney Disease Improving Global Outcomes Urine Output Criteria in Critically Ill Patients: A Secondary Analysis of a Multicenter Prospective Cohort Study.

Authors:  Jun-Ping Qin; Xiang-You Yu; Chuan-Yun Qian; Shu-Sheng Li; Tie-He Qin; Er-Zhen Chen; Jian-Dong Lin; Yu-Hang Ai; Da-Wei Wu; De-Xin Liu; Ren-Hua Sun; Zhen-Jie Hu; Xiang-Yuan Cao; Fa-Chun Zhou; Zhen-Yang He; Li-Hua Zhou; You-Zhong An; Yan Kang; Xiao-Chun Ma; Ming-Yan Zhao; Li Jiang; Yuan Xu; Bin Du
Journal:  Chin Med J (Engl)       Date:  2016-09-05       Impact factor: 2.628

10.  Rates, predictors, and mortality of sepsis-associated acute kidney injury: a systematic review and meta-analysis.

Authors:  Jiefeng Liu; Hebin Xie; Ziwei Ye; Fen Li; Lesan Wang
Journal:  BMC Nephrol       Date:  2020-07-31       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.